Symbol: |
EFHA2
|
Description: |
EF-hand domain family, member A2 [Source:HGNC Symbol;Acc:27820]
|
Location: |
Chr8:16884747-16980153[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:364
Gene |
Compound |
Gen_sig |
Exp_pattern |
EFHA2 |
11H-Indeno[1,2-c]isoquinolinium, 9-hydroxy-2,3,8-trimethoxy-6-methyl-, chloride |
0.037 |
Down |
EFHA2 |
Tesimide |
0.036 |
Up |
EFHA2 |
Indeno[1,2-c]isoquinoline-5,11-dione, 6-methyl- 5-(methylsulfonyloxy)-5,6,6a,11a-tetrahydro- 2,3,8-trimethoxy-, cis- |
0.043 |
Down |
EFHA2 |
MYCOTRIENINE-LIKE |
0.002 |
Up |
EFHA2 |
Morpholine-N-dithiocarbamate |
0.001 |
Up |
EFHA2 |
Neocuproin |
0.018 |
Up |
EFHA2 |
C.I. 37559 |
0.007 |
Down |
EFHA2 |
NSC 527353 |
0.044 |
Up |
EFHA2 |
NSC 600758 |
0.013 |
Up |
EFHA2 |
9-AC |
0.018 |
Down |
EFHA2 |
Camptothecin ethylglycinate ester hydrochloride |
0.043 |
Down |
EFHA2 |
Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt |
0.026 |
Down |
EFHA2 |
Imidazole, 1-(4-chlorophenyl)-4-(4-nitrophenyl)- |
0.001 |
Down |
EFHA2 |
Benzoic acid, 2-hydroxy-, (2,6-pyridinediyldiethylidyne)dihydrazide, manganese chloride complex |
0.015 |
Down |
EFHA2 |
4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride |
0.023 |
Up |
Expression pattern: Sensitivity / Resistance
Total:25 Current:4
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:30
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:3
Gene |
Gen_transcript |
miRNA |
miR_location |
EFHA2 |
ENST00000381952 |
hsa-mir-181d |
Chr19:13985724-13985746[+] |
EFHA2 |
ENST00000381952 |
hsa-mir-448 |
ChrX:114058087-114058108[+] |
EFHA2 |
ENST00000381952 |
hsa-mir-587 |
Chr6:107232015-107232035[+] |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|